xamoterol has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 1 studies
Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one) | Trials (2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one) | Recent Studies (post-2010) (2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one) |
---|---|---|---|---|---|
269 | 80 | 17 | 4,823 | 5 | 1,810 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoizey, G; Millart, H; Robinet, A | 1 |
1 other study(ies) available for xamoterol and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
Article | Year |
---|---|
PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning.
Topics: Adrenergic beta-Agonists; Androstadienes; Animals; Blotting, Western; Chromones; Coronary Circulation; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Heart Rate; Ischemic Preconditioning, Myocardial; Isoquinolines; Male; Morpholines; Myocardial Reperfusion Injury; Myocardium; Oxidopamine; Perfusion; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase C; Rats; Rats, Wistar; Sulfonamides; Wortmannin; Xamoterol | 2005 |